Mostrar el registro sencillo

dc.contributor.authorAit Eldjoudi, Djedjigaes_ES
dc.contributor.authorCordero Barreal, Alfonsoes_ES
dc.contributor.authorGonzález-Rodriguez, Maríaes_ES
dc.contributor.authorRuiz-Fernández, Claraes_ES
dc.contributor.authorFarrag, Yousofes_ES
dc.contributor.authorLago, Franciscaes_ES
dc.contributor.authorCapuozzo, Maurizioes_ES
dc.contributor.authorGonzález-Gay Mantecón, Miguel Ángel es_ES
dc.contributor.authorMera Varela, Antonioes_ES
dc.contributor.authorPino, Jesúses_ES
dc.contributor.authorGualillo, Orestees_ES
dc.contributor.otherUniversidad de Cantabriaes_ES
dc.date.accessioned2023-04-28T17:23:44Z
dc.date.available2023-04-28T17:23:44Z
dc.date.issued2022-03es_ES
dc.identifier.issn1661-6596es_ES
dc.identifier.issn1422-0067es_ES
dc.identifier.urihttps://hdl.handle.net/10902/28633
dc.description.abstractWhite adipose tissue (WAT) is a specialized tissue whose main function is lipid synthesis and triglyceride storage. It is now considered as an active organ secreting a plethora of hormones and cytokines namely adipokines. Discovered in 1994, leptin has emerged as a key molecule with pleiotropic functions. It is primarily recognized for its role in regulating energy homeostasis and food intake. Currently, further evidence suggests its potent role in reproduction, glucose metabolism, hematopoiesis, and interaction with the immune system. It is implicated in both innate and adaptive immunity, and it is reported to contribute, with other adipokines, in the cross-talking networks involved in the pathogenesis of chronic inflammation and immune-related diseases of the musculoskeletal system such as osteoarthritis (OA) and rheumatoid arthritis (RA). In this review, we summarize the most recent findings concerning the involvement of leptin in immunity and inflammatory responses in OA and RA.es_ES
dc.description.sponsorshipO.G. and F.L. are staff personnel (I3SNS stable researchers) of Xunta de Galicia (Servizo Galego de Saude, SERGAS) through a research-staff contract (ISCIII/SERGAS). C.R.F. is a predoctoral research scholar funded by ISCIII and FEDER (Exp.18/00188). M.G.R. is a recipient of a pre-doctoral contract funded by Xunta de Galicia (IN606A-2020/010). A.C.B. is a recipient of a pre-doctoral contract funded by Secretaría de Estado de Universidades, Investigación, Desarrollo e Innovación, Ministerio de Universidades (FPU2018-04165). O.G. and MAGG are members of the RICORS Programme, RD21/0002/0025 via ISCIII and FEDER. F.L. is a member of Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV). The work of O.G. and J.P. (PI17/00409 and PI20/00902), and F.L. (PI18/00821, PI21/01145) is funded by ISCIII and FEDER. O.G. is a beneficiary of a project funded by the Research Executive Agency of the European Union in the framework of MSCA-RISE Action of the H2020 Programme (project number 734899). O.G. is beneficiary of a grant funded by Xunta de Galicia, Conselleriá de Educación, Universidade e Formación Profesional, and Conselleriá de Economia, Emprego e Industria (GAIN), GPC IN607B2019/10.es_ES
dc.format.extent18 p.es_ES
dc.language.isoenges_ES
dc.publisherMDPIes_ES
dc.rightsAttribution 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.sourceInt J Mol Sci. 2022, 23(5), 2859es_ES
dc.subject.otherLeptines_ES
dc.subject.otherLeptin receptores_ES
dc.subject.otherRheumatoid arthritises_ES
dc.subject.otherOsteoarthritises_ES
dc.subject.otherInflammationes_ES
dc.titleLeptin in osteoarthritis and rheumatoid arthritis: player or bystander?es_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.relation.publisherVersionhttps://doi.org/10.3390/ ijms23052859es_ES
dc.rights.accessRightsopenAccesses_ES
dc.identifier.DOI10.3390/ijms23052859es_ES
dc.type.versionpublishedVersiones_ES


Ficheros en el ítem

Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo

Attribution 4.0 InternationalExcepto si se señala otra cosa, la licencia del ítem se describe como Attribution 4.0 International